StonvexLoading…
StonvexCore line items from ANGX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 |
|---|---|---|---|
Revenue | $321.56M | $96.52M | $202.44M |
Operating Income | $-164.11M | $-86.72M | $12.36M |
Net Income | $-170.48M | $-88.27M | $13.36M |
EPS (Diluted) | $-1.10 | $-0.64 | $0.10 |
Total Assets | $241.41M | $111.38M | $46.88M |
Total Liabilities | $267.19M | $94.67M | $5.56M |
Cash & Equivalents | $44.08M | $7.21M | $25.20M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available |
Shares Outstanding | 169.10M | 144.40M | 139.87M |